Research output per year
Research output per year
Personal profile
Academic discipline
PHARMACOLOGY
Fingerprint
Dive into the research topics where Lucia Lisi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country level (based on research outputs with Scopus ID). Dive into details by clicking on the dots.
-
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment
Lisi, L., Martire, M., Navarra, P., Graziani, G., Lacal, P. M. & Graziani, G., 2022, In: Pharmacological Research. 175, p. 105997-N/AResearch output: Contribution to journal › Article
-
The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF
Lisi, L., Martire, M., Navarra, P., Chiavari, M. & Ciotti, G. M. P., 2022, In: Growth Factors. p. 1-9 9 p.Research output: Contribution to journal › Article
-
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
Lisi, L., Lacal, P. M., Barbaccia, M. L. & Graziani, G., 2020, In: Biochemical Pharmacology. 2020, p. 114169-114182 14 p.Research output: Contribution to journal › Article
10 Citations (Scopus) -
Development of an uplc-ms/ms method for quantitative analysis of clotrimazole in human plasma samples
Lisi, L. & Navarra, P., 2020, In: Separations. 7, p. 1-9 9 p.Research output: Contribution to journal › Article
-
DNA inhibitors for the treatment of brain tumors
Lisi, L., Navarra, P., Chiavari, M., Lacal, P. M. & Graziani, G., 2020, In: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2020, p. 1-13-13Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)